HEMISPHERX BIOPHARMA INC Business Finance Contracts & Agreements
73 Contracts & Agreements
- Equity Distribution Agreements (4 contracts)
- Note Agreements (8)
- Purchase Agreements (14)
- Registration Rights Agreements (2)
- Security Agreements (5)
- Stock Agreements (15)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Waiver Agreements (2)
- Warrant Agreements (20)
- Form of Securities Purchase Agreement, dated as of September 30, 2024, by and among the Company and the investor parties thereto (Filed With SEC on October 1, 2024)
- Form of Class D Warrants to Purchase Common Stock (Filed With SEC on October 1, 2024)
- Form of Class C Warrants to Purchase Common Stock (Filed With SEC on October 1, 2024)
- Atlas Registration Rights Agreement (Filed With SEC on April 1, 2024)
- Atlas Equity Purchase Agreement (Filed With SEC on April 1, 2024)
- Description of Common Stock (Filed With SEC on April 1, 2024)
- Promissory Note dated February 16, 2024, between AIM ImmunoTech Inc. and Streeterville Capital, LLC (Filed With SEC on February 20, 2024)
- Note Purchase Agreement dated February 16, 2024, between AIM ImmunoTech Inc. and Streeterville Capital, LLC (Filed With SEC on February 20, 2024)
- Equity Distribution Agreement, dated as of April 19, 2023, by and between AIM Immunotech Inc. and Maxim Group LLC (Filed With SEC on April 19, 2023)
- Description of Common Stock (Filed With SEC on March 31, 2023)
- October 21, 2022 Fourth Amendment to Agreement of Sale and Purchase with Acellories, Inc (Filed With SEC on November 14, 2022)
- Amendment to the November 14, 2017 Second Amended and Restated Rights Agreement as of November 9, 2022, by and between AIM ImmunoTech Inc. (f/k/a Hemispherx Biopharma, Inc.) and... (Filed With SEC on November 14, 2022)
- August 2, 2022 Second Amendment to Agreement of Sale and Purchase with Acellories, Inc (Filed With SEC on August 15, 2022)
- June 27, 2022 First Amendment to Agreement of Sale and Purchase with Acellories, Inc (Filed With SEC on August 15, 2022)
- March 3, 2022 Agreement of Sale and Purchase with Acellories, Inc for sale of 783 Jersey Avenue, New Brunswick, NJ building (Filed With SEC on March 31, 2022)
- Description of Common Stock (Filed With SEC on March 31, 2022)
- April 19, 2021 Purchase and Sale Agreement with Phoenix Equipment Corporation, Branford Auctions, LLC and Perry Videx LLC (Filed With SEC on May 17, 2021)
- Description of Common Stock (Filed With SEC on March 31, 2021)
- Description of Common Stock (Filed With SEC on March 30, 2020)
- December 5, 2019 Security Agreement between the Company and Atlas Sciences, LLC (Filed With SEC on December 11, 2019)
- December 5, 2019 Secured Promissory Note from the Company to Atlas Sciences, LLC (Filed With SEC on December 11, 2019)
- December 5, 2019 Note Purchase Agreement between the Company and Atlas Sciences, LLC (Filed With SEC on December 11, 2019)
- Form of Warrant (Filed With SEC on September 27, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on September 27, 2019)
- Underwriting Agreement, dated September 25, 2019 between the Company and A.G.P./Alliance Global Partners, LLC (Filed With SEC on September 27, 2019)
- Form of Representatives Warrant (Filed With SEC on September 24, 2019)
- Underwriting Agreement (Filed With SEC on September 24, 2019)
- Form of Warrant (Filed With SEC on September 6, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on September 6, 2019)
- Form of Restricted Stock Award (Filed With SEC on August 26, 2019)
- Salary Reduction and Restricted Stock Award Memo (Filed With SEC on August 26, 2019)
- Security Agreement dated August 5, 2019 with Chicago Ventures Partners, L.P (Filed With SEC on August 14, 2019)
- Secured Promissory Note dated August 5, 2019 issued to Chicago Ventures Partners, L.P (Filed With SEC on August 14, 2019)
- Note Purchase Agreement dated August 5, 2019 with Chicago Ventures Partners, L.P (Filed With SEC on August 14, 2019)
- Equity Distribution Agreement, dated as of July 19, 2019, by and between Hemispherx Biopharma, Inc. and Maxim Group LLC (Filed With SEC on July 22, 2019)
- March 13, 2019 amendment to the September 28, 2018 Secured Convertible Promissory Note from the Company to Iliad Research and Trading, L.P (Filed With SEC on March 15, 2019)
- Warrant Agency Agreement with American Stock Transfer & Trust Company, LLC (Filed With SEC on March 8, 2019)
- Revised Form of Warrant Certificate for Rights Offering (Filed With SEC on February 27, 2019)
- Form of Warrant Agreement (Filed With SEC on February 6, 2019)
- Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 6, 2019)
